Platelet activation and aggregation during cardiopulmonary bypass.

Platelet Functions in Cardiopulmonary Bypass Surgery.

In vivo platelet function following cardiopulmonary bypass.

Shear stress platelet activation test and "rebleeding" in patients undergoing cardiopulmonary bypass.

Volatile anaesthesia during cardiopulmonary bypass.

Effect of cardiopulmonary bypass on platelet mitochondrial respiration and correlation with aggregation and bleeding: a pilot study.

Platelet function during cardiopulmonary bypass using multiple electrode aggregometry: comparison of centrifugal and roller pumps.

Determinants of platelet-leukocyte aggregation and platelet activation in stroke.

Cardiopulmonary dysfunctions caused by ADP-induced platelet aggregation.

Platelet protection by aprotinin in cardiopulmonary bypass: electron microscopic study.

Embolic activity during in vivo cardiopulmonary bypass.

Propranolol binding in plasma during cardiopulmonary bypass.

Mean arterial blood pressure during cardiopulmonary bypass.

Coagulation defects in neonates during cardiopulmonary bypass.

Release of vasoactive substances during cardiopulmonary bypass.

Administration of vancomycin during cardiopulmonary bypass.

Fluid distribution kinetics during cardiopulmonary bypass.

Role of corticosteroids during cardiopulmonary bypass.

Emergent Cardiopulmonary Bypass during Cardiac Surgery.

Platelets activation is associated with elevated plasma mitochondrial DNA during cardiopulmonary bypass.

Leukocyte activation with increased expression of CR3 receptors during cardiopulmonary bypass.

Coronary haemodynamics and myocardial metabolism during cardiopulmonary bypass.

Assessment of neonatal platelet adhesion, activation, and aggregation.

Hypoxia impairs agonist-induced integrin αIIbβ3 activation and platelet aggregation.

Protection strategies during cardiopulmonary bypass: ventilation, anesthetics and oxygen.

Suggest Documents

Platelet Functions in Cardiopulmonary Bypass Surgery.

In vivo platelet function following cardiopulmonary bypass.

Shear stress platelet activation test and "rebleeding" in patients undergoing cardiopulmonary bypass.

Volatile anaesthesia during cardiopulmonary bypass.

Effect of cardiopulmonary bypass on platelet mitochondrial respiration and correlation with aggregation and bleeding: a pilot study.

Platelet function during cardiopulmonary bypass using multiple electrode aggregometry: comparison of centrifugal and roller pumps.

Determinants of platelet-leukocyte aggregation and platelet activation in stroke.

Cardiopulmonary dysfunctions caused by ADP-induced platelet aggregation.

Platelet protection by aprotinin in cardiopulmonary bypass: electron microscopic study.

Embolic activity during in vivo cardiopulmonary bypass.

Propranolol binding in plasma during cardiopulmonary bypass.

Mean arterial blood pressure during cardiopulmonary bypass.

Coagulation defects in neonates during cardiopulmonary bypass.

Release of vasoactive substances during cardiopulmonary bypass.

Administration of vancomycin during cardiopulmonary bypass.

Fluid distribution kinetics during cardiopulmonary bypass.

Role of corticosteroids during cardiopulmonary bypass.

Emergent Cardiopulmonary Bypass during Cardiac Surgery.

Platelets activation is associated with elevated plasma mitochondrial DNA during cardiopulmonary bypass.

Leukocyte activation with increased expression of CR3 receptors during cardiopulmonary bypass.

Coronary haemodynamics and myocardial metabolism during cardiopulmonary bypass.

Assessment of neonatal platelet adhesion, activation, and aggregation.

Hypoxia impairs agonist-induced integrin αIIbβ3 activation and platelet aggregation.

Protection strategies during cardiopulmonary bypass: ventilation, anesthetics and oxygen.

Platelet activation and aggregation during cardiopulmonary bypass.

Recommend Documents

Follow Us